2 reports

Phase ##/ ## study of Bendamustine and Rituximab for relapsed or refractory indolent B-cell non- Hodgkin lymphoma and mantle cell lymphoma.

  • Biopharmaceutical
  • Cancer
  • Clinical Trial
  • Lymphoma
  • Central America
  • 3.2.1 Follicular Lymphoma Drug Profiles
  • Untitled

In 2017, ## trial is initiated to date.

  • Biopharmaceutical
  • Cancer
  • Clinical Trial
  • Lymphoma
  • Central America